These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 37055547)
1. The role of ChREBP in carbohydrate sensing and NAFLD development. Régnier M; Carbinatti T; Parlati L; Benhamed F; Postic C Nat Rev Endocrinol; 2023 Jun; 19(6):336-349. PubMed ID: 37055547 [TBL] [Abstract][Full Text] [Related]
2. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice. Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348 [TBL] [Abstract][Full Text] [Related]
3. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a. Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759 [TBL] [Abstract][Full Text] [Related]
4. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet. Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722 [TBL] [Abstract][Full Text] [Related]
5. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases. Iizuka K Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488 [TBL] [Abstract][Full Text] [Related]
6. Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis. Gnoni A; Di Chiara Stanca B; Giannotti L; Gnoni GV; Siculella L; Damiano F Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162967 [TBL] [Abstract][Full Text] [Related]
7. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860 [TBL] [Abstract][Full Text] [Related]
8. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933 [TBL] [Abstract][Full Text] [Related]
9. NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet. Daniel PV; Dogra S; Rawat P; Choubey A; Khan AS; Rajak S; Kamthan M; Mondal P J Biol Chem; 2021; 296():100714. PubMed ID: 33930463 [TBL] [Abstract][Full Text] [Related]
10. Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein. Agius L Proc Nutr Soc; 2016 Feb; 75(1):10-18. PubMed ID: 26264689 [TBL] [Abstract][Full Text] [Related]
11. 3,5-diiodo-L-thyronine increases de novo lipogenesis in liver from hypothyroid rats by SREBP-1 and ChREBP-mediated transcriptional mechanisms. Gnoni A; Siculella L; Paglialonga G; Damiano F; Giudetti AM IUBMB Life; 2019 Jul; 71(7):863-872. PubMed ID: 30707786 [TBL] [Abstract][Full Text] [Related]
12. Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose. Tian H; Fang Y; Liu W; Wang J; Zhao J; Tang H; Yin Y; Hu Y; Peng J J Ethnopharmacol; 2023 Jan; 301():115806. PubMed ID: 36216198 [TBL] [Abstract][Full Text] [Related]
14. Liver-Derived S100A6 Propels β-Cell Dysfunction in NAFLD. Dogra S; Das D; Maity SK; Paul A; Rawat P; Daniel PV; Das K; Mitra S; Chakrabarti P; Mondal P Diabetes; 2022 Nov; 71(11):2284-2296. PubMed ID: 35899967 [TBL] [Abstract][Full Text] [Related]
15. New insights into the inter-organ crosstalk mediated by ChREBP. Carbinatti T; Régnier M; Parlati L; Benhamed F; Postic C Front Endocrinol (Lausanne); 2023; 14():1095440. PubMed ID: 36923222 [TBL] [Abstract][Full Text] [Related]
16. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease. Ter Horst KW; Vatner DF; Zhang D; Cline GW; Ackermans MT; Nederveen AJ; Verheij J; Demirkiran A; van Wagensveld BA; Dallinga-Thie GM; Nieuwdorp M; Romijn JA; Shulman GI; Serlie MJ Diabetes Care; 2021 Feb; 44(2):489-498. PubMed ID: 33293347 [TBL] [Abstract][Full Text] [Related]
17. Histone modifications in fatty acid synthase modulated by carbohydrate responsive element binding protein are associated with non‑alcoholic fatty liver disease. Cai C; Yu H; Huang G; Du X; Yu X; Zhou Y; Shen W Int J Mol Med; 2018 Sep; 42(3):1215-1228. PubMed ID: 29786745 [TBL] [Abstract][Full Text] [Related]
18. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R J Clin Invest; 2010 Dec; 120(12):4316-31. PubMed ID: 21084751 [TBL] [Abstract][Full Text] [Related]
19. [Role of increased activity of carbohydrate response element binding protein in excessive lipid accumulation in the liver of type 2 diabetic db/db mouse]. Huo M; Zang HL; Zhang DJ; Wang B; Wu J; Zhang XY; Chen LH; Li J; Yang JC; Guan YF Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 41(3):307-12. PubMed ID: 19727214 [TBL] [Abstract][Full Text] [Related]
20. HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP. Lane EA; Choi DW; Garcia-Haro L; Levine ZG; Tedoldi M; Walker S; Danial NN Mol Cell; 2019 Jul; 75(2):357-371.e7. PubMed ID: 31227231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]